Baxter Earns CE Mark for Syringe-Infusion System Post author:Sam Post published:May 21, 2020 Post category:Devices & Diagnostics Letter The device should be available in Europe, Australia and New Zealand in June. Source: Devices & Diagnostics Letter You Might Also Like Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru August 20, 2020 Trump Criticizes FDA Delay of Convalescent Plasma EUA August 20, 2020 First Genetic Test for Fragile X Syndrome Cleared February 24, 2020